# Tinker Biology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tinker-biology

- Industry: Food
- Headquarters: Hangzhou, China
- Website: www.tinkerbio.com
- Latest round: Series A (Mar 3, 2023)
- Investors on record: 4

## About

Established in 2017 and based in Hangzhou, China, Tinker Biology is a microfluidic chip CDMO service provider that focuses on the development and production of food safety on-site rapid detection instruments and reagents based on microfluidic chip technology. The company has a 1000 square meters microfluidic laboratory and a 2000 square meters GMP standard plant. Tinker Biology has also obtained more than 50 authorized patents and soft documents, and has been awarded as National High-tech Enterprise, Hangzhou Qinglan Enterprise and Zhejiang Science and Technology Small and Medium-sized Enterprise. Dr. Jiaming Ye, the founder of the company, worked at CapitalBio Corp.

The company provides microfluidic product design and development and manufacturing solutions for medical in vitro diagnostics, organ-on-a-chip, nano drug/material synthesis, food safety/environmental protection testing and other industries, based on a full chain of microfluidic technology platform.  The services provided by the company include bioanalysis, immunoassays, molecular diagnostics, chemical synthesis, droplet manipulation and cellular analysis.

## Funding rounds

- Series A, Mar 3, 2023 — Panlin Capital
- Series A, Nov 5, 2021 — Qikai Investment Management, Quaero Life Science
- Angel, Feb 27, 2017 — TTGG Ventures

## Investors

- TTGG Ventures (https://capitalatlas.ai/funds/ttgg-ventures) — Angel
- Qikai Investment Management — Series A
- Quaero Life Science — Series A
- Panlin Capital (https://capitalatlas.ai/funds/panlin-capital) — Series A